Drug Trial Radar · NCT00930644
Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
Last checked: Nov 19, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
88
Actual
Start
Sep 21, 2009
Primary completion
Jan 24, 2013
Study completion Jan 24, 2013
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Nycomed Germany GmbH
- First posted
- Jun 30, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a 2-year open label extension study to collect long term efficacy and safety data from patients who have completed the 24-weeks of study drug dosing in CL0600-020.
Conditions
- Short Bowel Syndrome
Interventions
teduglutideDrug
0.05 mg/kg/day subcutaneously taken once per day for 24 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in PN/IV Volume by VisitTime frame: 24 months
- Absolute Change in PN/IV Volume by VisitTime frame: 24 months
Locations
23 sites in 9 countries. Site status is shown where the registry gives one.
Scripps Clinic & Research Foundation
La Jolla, California
Mount Sinai Medical Center
New York, New York
Cleveland Clinic Foundation
Cleveland, Ohio
University of Pennslyvania
Philadelphia, Pennsylvania
University Of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
Royal Alexandra Hospital
Edmonton, Alberta, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
University Health Network - Toronto General Hospital
Toronto, Ontario, Canada
Rigshospitalet
Copenhagen, Denmark
Hôpital Beaujon
Clichy, France
Hopital de l'Archet 2
Nice, France
Universitaetsklinikum Tuebingen Medizinische Klinik I
Tübingen, Baden-Wurttemberg, Germany
Med. Klinik m.S. Hepatologie und Gastroenterologie
Berlin, State of Berlin, Germany
Azienda Universitaria Policlinico Federico II
Naples, Italy
Wojewodzki Szpital Specjalistyczny im. M. Pirogowa, Pracownia Leczenia Zywieniowego
Lodz, Poland
Samodzielny Publiczny Szpital Kliniczny nr 4, Klinika Chirurgii Ogolnej i Transplantacyjnej
Lublin, Poland
Pracownia Żywienia Klinicznego
Olsztyn, Poland
Samodzielny Publiczny Szpital Kliniczny-Im.prof W.Orłowskiego CMKP
Warsaw, Poland
Hospital Universitario de Bellvitge
Barcelona, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
St. Marks Hospital
Harrow, United Kingdom
University College London Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.